-
Bornovalova MA, Hicks BM, Iacono WG, et al. (2009) Stability, change, and heritability of borderline personality disorder traits from adolescence to adulthood: A longitudinal twin study. Dev Psychopathol 21(4): 1335–1353.
pubmed_reference_list
-
Crawford MJ, Sanatinia R, Barrett B, et al. (2018) Lamotrigine for people with borderline personality disorder: A RCT. Health Technol Assess 22(17): 1–68.
pubmed_reference_list
-
Ekselius L. (2017) Personlighetssyndrom : kliniska riktlinjer för utredning och behandling [Personality disorders: Clinical guidelines for assessment and treatment]. Svenska psykiatriska föreningen.
pubmed_reference_list
-
Gartlehner G, Crotty K, Kennedy S, et al. (2021) Pharmacological treatments for borderline personality disorder: A systematic review and meta-analysis. CNS Drugs 35(10): 1053–1067.
pubmed_reference_list
-
Gibbons RD, Hur K, Quinn PD. (2021) Concomitant opioid and benzodiazepine use and risk of suicide attempt and intentional self-harm: Pharmacoepidemiologic study. Drug Alcohol Depend 228: 109046.
pubmed_reference_list
-
Hastrup LH, Jennum P, Ibsen R, et al. (2019) Societal costs of borderline personality disorders: A matched-controlled nationwide study of patients and spouses. Acta Psychiatr Scand 140(5): 458–467.
pubmed_reference_list
-
Keepers GA, Fochtmann LJ, Anzia JM, et al. (2024) The American Psychiatric Association practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 181(11): 1024–1028.
pubmed_reference_list
-
Kouppis E, Ekselius L. (2020) Validity of the personality disorder diagnosis in the Swedish National Patient Register. Acta Psychiatr Scand 141(5): 432–438.
pubmed_reference_list
-
Lichtenstein P, Halldner L, Zetterqvist J, et al. (2012) Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 367(21): 2006–2014.
pubmed_reference_list
-
Ludvigsson JF, Almqvist C, Bonamy AK, et al. (2016) Registers of the Swedish total population and their use in medical research. Eur J Epidemiol 31(2): 125–136.
pubmed_reference_list
-
Ludvigsson JF, Andersson E, Ekbom A, et al. (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11: 450.
pubmed_reference_list
-
Lundberg J, Cars T, Lööv S, et al. (2022) Clinical and societal burden of incident major depressive disorder: A population-wide cohort study in Stockholm. Acta Psychiatr Scand 146(1): 51–63.
pubmed_reference_list
-
Muller AE, Clausen T, Sjøgren P, et al. (2019) Prescribed opioid analgesic use developments in three Nordic countries, 2006–2017. Scand J Pain 19(2): 345–353.
pubmed_reference_list
-
National Board of Health and Welfare (2023) Diagnostik och läkemedelsbehandling vid adhd Förekomst, trend och könsskillnader.
pubmed_reference_list
-
National Collaborating Centre for Mental Health (2009) National Institute for Health and Clinical Excellence: Guidance. Borderline Personality Disorder: Treatment and Management. British Psychological Society Copyright © 2009, The British Psychological Society & The Royal College of Psychiatrists.
pubmed_reference_list
-
National Health and Medical Research Council (2012) Clinical practice guideline for the management of borderline personality disorder. National Health and Medical Research Council.
pubmed_reference_list
-
Nutt DJ, Blier P. (2016) Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology. J Psychopharmacol 30(5): 413–415.
pubmed_reference_list
-
Pascual JC, Martín-Blanco A, Soler J. (2021) Twenty-year trends in the psychopharmacological treatment of outpatients with borderline personality disorder: A cross-sectional naturalistic study in Spain. CNS Drugs 35(9): 1023–1032.
pubmed_reference_list
-
Paton C, Crawford MJ, Bhatti SF, et al. (2015) The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services. J Clin Psychiatry 76(4): e512–e518.
pubmed_reference_list
-
Piotrowska N, Klukowska-Rötzler J, Lehmann B, et al. (2019) Presentations Related to Acute Paracetamol Intoxication in an Urban Emergency Department in Switzerland. Emerg Med Int 2019: 3130843.
pubmed_reference_list
-
Simonsen S, Bateman A, Bohus M, et al. (2019) European guidelines for personality disorders: Past, present and future. Borderline Personal Disord Emot Dysregul 6: 9.
pubmed_reference_list
-
Skoglund C, Tiger A, Ruck C, et al. (2019) Familial risk and heritability of diagnosed borderline personality disorder: A register study of the Swedish population. Mol Psychiatry 26(3): 999–1008.
pubmed_reference_list
-
Solmi M, Radua J, Olivola M, et al. (2022) Age at onset of mental disorders worldwide: Large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry 27(1): 281–295.
pubmed_reference_list
-
Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, et al. (2022. a) Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev 11(11): Cd012956.
pubmed_reference_list
-
Stoffers-Winterling JM, Storebø OJ, Simonsen E, et al. (2022. b) Perspectives on dialectical behavior therapy and mentalization-based therapy for borderline personality disorder: Same, different, complementary? Psychol Res Behav Manag 15: 3179–3189.
pubmed_reference_list
-
Stoffers J, Vollm BA, Rucker G, et al. (2010) Pharmacological interventions for borderline personality disorder. Cochrane Database Syst Rev. Epub ahead of print 18 June 2010. DOI: 10.1002/14651858.CD005653.pub2.
DOI: 10.1002/14651858.CD005653.pub2
pubmed_reference_list
-
Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al. (2020) Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 5(5): Cd012955.
pubmed_reference_list
-
Swedish Medical Agency (2020) Förskrivning av opioider i Sverige: Läkemedel, doser och diagnoser [Prescription of opioids in Sweden: Drugs, doses and diagnoses].
pubmed_reference_list
-
Swedish Medical Agency (2021) Utvidga kunskapen om lugnande medel och sömnmede. [Expand the knowledge on anxiolytic-, hypnotic- and sedative agents.].
pubmed_reference_list
-
Tate AE, Sahlin H, Liu S, et al. (2022) Borderline personality disorder: Associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors. Mol Psychiatry 27(5): 1–8.
pubmed_reference_list
-
Torgersen S. (2009) The nature (and nurture) of personality disorders. Scand J Psychol 50(6): 624–632.
pubmed_reference_list
-
Videler AC, Hutsebaut J, Schulkens JEM, et al. (2019) A life span perspective on borderline personality disorder. Curr Psychiatry Rep 21(7): 51.
pubmed_reference_list
-
WHO Collaborating Centre for Drug Statistics Methodology (2024) Guidelines for ATC classification and DDD assignment 2025.
pubmed_reference_list
-
Winsper C, Bilgin A, Thompson A, et al. (2020) The prevalence of personality disorders in the community: A global systematic review and meta-analysis. Br J Psychiatry 216(2): 69–78.
pubmed_reference_list
-
Zanarini MC, Frankenburg FR, Bradford Reich D, et al. (2015) Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up. J Clin Psychopharmacol 35(1): 63–67.
pubmed_reference_list
-
Zetterqvist J, Asherson P, Halldner L, et al. (2013) Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: Total population study of trends and discontinuation patterns 2006–2009. Acta Psychiatr Scand 128(1): 70–77.
pubmed_reference_list